{"id":"toloxatone","rwe":[],"tags":[{"label":"Monoamine Oxidase Inhibitors","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Amine oxidase [flavin-containing] A","category":"target"},{"label":"MAOA","category":"gene"},{"label":"MAOB","category":"gene"},{"label":"N06AG03","category":"atc"},{"label":"Active","category":"status"},{"label":"Depressive disorder","category":"indication"},{"label":"Antidepressive Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Monoamine Oxidase Inhibitors","category":"pharmacology"},{"label":"Psychotropic Drugs","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":30.852,"date":"","count":3,"signal":"Phaeochromocytoma","source":"DrugCentral FAERS","actionTaken":"Reported 3 times (LLR=31)"}],"drugInteractions":[{"url":"/drug/alpha/beta-agonists","drug":"Alpha/Beta Agonists","action":"Use caution","effect":"MAO Inhibitors may enhance the hypertensive effect of Alpha/Beta-Agonists","source":"DrugCentral","drugSlug":"alpha/beta-agonists"},{"url":"/drug/amphetamines","drug":"Amphetamines","action":"Use caution","effect":"MAO Inhibitors may enhance the hypertensive effect of amphetamines","source":"DrugCentral","drugSlug":"amphetamines"},{"url":"/drug/indirectly-acting-sympathomimetic-amines","drug":"Indirectly Acting Sympathomimetic Amines","action":"Contraindicated","effect":"potentially fatal hypertensive crisis","source":"DrugCentral","drugSlug":"indirectly-acting-sympathomimetic-amines"},{"url":"/drug/selective-serotonin-reuptake-inhibitors","drug":"Selective Serotonin Reuptake Inhibitors","action":"Contraindicated","effect":"serotonin syndrome","source":"DrugCentral","drugSlug":"selective-serotonin-reuptake-inhibitors"},{"url":"/drug/serotonin/norepinephrine-reuptake-inhibitors","drug":"Serotonin/Norepinephrine Reuptake Inhibitors","action":"Contraindicated","effect":"serotonin syndrome","source":"DrugCentral","drugSlug":"serotonin/norepinephrine-reuptake-inhibitors"},{"url":"/drug/tricyclic-antidepressants","drug":"Tricyclic Antidepressants","action":"Contraindicated","effect":"very toxic and sometimes fatal reactions the serotonin syndrome or similar","source":"DrugCentral","drugSlug":"tricyclic-antidepressants"},{"url":"/drug/buspirone","drug":"buspirone","action":"Use caution","effect":"May increase blood pressure","source":"DrugCentral","drugSlug":"buspirone"},{"url":"/drug/dextromethorphan","drug":"dextromethorphan","action":"Contraindicated","effect":"fatal/non-fatal reactions","source":"DrugCentral","drugSlug":"dextromethorphan"},{"url":"/drug/levodopa","drug":"levodopa","action":"Contraindicated","effect":"life-threatening hypertensive reaction","source":"DrugCentral","drugSlug":"levodopa"},{"url":"/drug/methyldopa","drug":"methyldopa","action":"Use caution","effect":"hypertension may occur","source":"DrugCentral","drugSlug":"methyldopa"},{"url":"/drug/mirtazapine","drug":"mirtazapine","action":"Contraindicated","effect":"Label warning","source":"DrugCentral","drugSlug":"mirtazapine"},{"url":"/drug/pethidine","drug":"pethidine","action":"Use caution","effect":"potentially life-threatening reaction","source":"DrugCentral","drugSlug":"pethidine"},{"url":"/drug/phenylephrine","drug":"phenylephrine","action":"Contraindicated","effect":"potentially fatal hypertensive crisis","source":"DrugCentral","drugSlug":"phenylephrine"},{"url":"/drug/tramadol","drug":"tramadol","action":"Use caution","effect":"serotonin syndrome","source":"DrugCentral","drugSlug":"tramadol"},{"url":"/drug/tryptophan","drug":"tryptophan","action":"Contraindicated","effect":"severe behavioural and neurological signs of toxicity","source":"DrugCentral","drugSlug":"tryptophan"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TOLOXATONE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:02:37.550204+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:02:43.044307+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TOLOXATONE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:02:43.594680+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Monoamine oxidase A inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:44.695391+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL18116/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:44.303493+00:00"}},"allNames":"humoryl","offLabel":[],"synonyms":["humoryl","toloxatone","taloxotone"],"timeline":[],"approvals":[],"brandName":"Humoryl","ecosystem":[{"indication":"Depressive disorder","otherDrugs":[{"name":"amitriptyline","slug":"amitriptyline","company":"Astrazeneca"},{"name":"amoxapine","slug":"amoxapine","company":"Lederle"},{"name":"bupropion","slug":"bupropion","company":"Glaxosmithkline"},{"name":"citalopram","slug":"citalopram","company":"Forest Labs"}],"globalPrevalence":280000000}],"mechanism":{"target":"Amine oxidase [flavin-containing] A","targets":[{"gene":"MAOA","source":"DrugCentral","target":"Amine oxidase [flavin-containing] A","protein":"Amine oxidase [flavin-containing] A"},{"gene":"MAOB","source":"DrugCentral","target":"Amine oxidase [flavin-containing] B","protein":"Amine oxidase [flavin-containing] B"}],"modality":"Small Molecule","drugClass":"Monoamine Oxidase Inhibitors","explanation":"","oneSentence":"","technicalDetail":"Toloxatone selectively and reversibly inhibits monoamine oxidase A (MAO-A), preventing the breakdown of monoamines such as serotonin, norepinephrine, and dopamine, which are involved in mood regulation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2702","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TOLOXATONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T16:02:01.468880","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:02:46.213636+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cyclizine","drugSlug":"cyclizine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"donepezil","drugSlug":"donepezil","fdaApproval":"1996-11-25","patentExpiry":"Sep 23, 2037","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"isocarboxazid","drugSlug":"isocarboxazid","fdaApproval":"1959-07-01","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"istradefylline","drugSlug":"istradefylline","fdaApproval":"2019-08-27","patentExpiry":"Sep 5, 2027","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"linezolid","drugSlug":"linezolid","fdaApproval":"2000-04-18","genericCount":24,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"menadione","drugSlug":"menadione","fdaApproval":"","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"methylthioninium chloride","drugSlug":"methylthioninium-chloride","fdaApproval":"","relationship":"same-target"},{"drugName":"pargyline","drugSlug":"pargyline","fdaApproval":"1961-01-01","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"phenelzine","drugSlug":"phenelzine","fdaApproval":"1961-06-09","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"pioglitazone","drugSlug":"pioglitazone","fdaApproval":"1999-07-15","genericCount":13,"patentStatus":"Off-patent — generic available","relationship":"same-target"}],"genericName":"toloxatone","indications":{"approved":[{"name":"Depressive disorder","source":"DrugCentral","snomedId":35489007,"regulator":"FDA","usPrevalence":21000000,"globalPrevalence":280000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"cyclizine","brandName":"cyclizine","genericName":"cyclizine","approvalYear":"","relationship":"same-target"},{"drugId":"donepezil","brandName":"donepezil","genericName":"donepezil","approvalYear":"1996","relationship":"same-target"},{"drugId":"isocarboxazid","brandName":"isocarboxazid","genericName":"isocarboxazid","approvalYear":"1959","relationship":"same-target"},{"drugId":"istradefylline","brandName":"istradefylline","genericName":"istradefylline","approvalYear":"2019","relationship":"same-target"},{"drugId":"linezolid","brandName":"linezolid","genericName":"linezolid","approvalYear":"2000","relationship":"same-target"},{"drugId":"menadione","brandName":"menadione","genericName":"menadione","approvalYear":"","relationship":"same-target"},{"drugId":"methylthioninium-chloride","brandName":"methylthioninium chloride","genericName":"methylthioninium chloride","approvalYear":"","relationship":"same-target"},{"drugId":"pargyline","brandName":"pargyline","genericName":"pargyline","approvalYear":"1961","relationship":"same-target"},{"drugId":"phenelzine","brandName":"phenelzine","genericName":"phenelzine","approvalYear":"1961","relationship":"same-target"},{"drugId":"pioglitazone","brandName":"pioglitazone","genericName":"pioglitazone","approvalYear":"1999","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005364","UNII":"5T206015T5","CHEBI":"CHEBI:134870","INN_ID":"3429","RXNORM":"38382","UMLSCUI":"C0076804","chemblId":"CHEMBL18116","ChEMBL_ID":"CHEMBL18116","KEGG_DRUG":"D02559","DRUGBANK_ID":"DB09245","PUBCHEM_CID":"34521","MESH_SUPPLEMENTAL_RECORD_UI":"C010798"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.6 hours","clearance":"11.0 mL/min/kg","bioavailability":"56%","fractionUnbound":"0.49%","volumeOfDistribution":"1.5 L/kg"},"publicationCount":82,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N06AG03","allCodes":["N06AG03"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1984","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:02:46.213636+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}